Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Cho

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Bone Marrow Transplantation|July 13, 2021
The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplantAna Alarcon Tomas, Karissa Whiting, Molly Maloy, et al.
Journal of Hematology & Oncology|October 22, 2018
Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCCFlorent Malard, Myriam Labopin, Christina Cho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2019
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Meier Hsu, Ann A Jakubowski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 29, 2018
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell TransplantationCarlos Rondon-Clavo, Michael Scordo, Patrick Hilden, et al.
Transplantation and Cellular Therapy|May 11, 2022
Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell TransplantationParastoo B Dahi, Andrew Lin, Michael Scordo, et al.
Science Advances|March 6, 2021
Nicotinic regulation of local and long-range input balance drives top-down attentional circuit maturationElisa N Falk, Kevin J Norman, Yury Garkun, et al.
Transplantation and Cellular Therapy|December 19, 2024
Health-Related Values Discussions with Patients Undergoing Allogeneic and Autologous Stem Cell Transplant: Feasibility and Acceptability of an Early Primary Palliative Care InterventionAbigail G Cohen, Christina Cho, Emily Patterson, et al.
Molecular Cancer Research : MCR|November 15, 2022
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer CellsNoreen McBrearty, Christina Cho, Jinyun Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 5, 2019
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34<sup>+</sup> Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Valkal Bhatt, Patrick Hilden, et al.
Blood Advances|October 14, 2022
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemiaWarren B Fingrut, Boglarka Gyurkocza, Jessica Flynn, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Bone Marrow Transplantation|July 13, 2021
The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplantAna Alarcon Tomas, Karissa Whiting, Molly Maloy, et al.
Journal of Hematology & Oncology|October 22, 2018
Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCCFlorent Malard, Myriam Labopin, Christina Cho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2019
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Meier Hsu, Ann A Jakubowski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 29, 2018
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell TransplantationCarlos Rondon-Clavo, Michael Scordo, Patrick Hilden, et al.
Transplantation and Cellular Therapy|May 11, 2022
Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell TransplantationParastoo B Dahi, Andrew Lin, Michael Scordo, et al.
Science Advances|March 6, 2021
Nicotinic regulation of local and long-range input balance drives top-down attentional circuit maturationElisa N Falk, Kevin J Norman, Yury Garkun, et al.
Transplantation and Cellular Therapy|December 19, 2024
Health-Related Values Discussions with Patients Undergoing Allogeneic and Autologous Stem Cell Transplant: Feasibility and Acceptability of an Early Primary Palliative Care InterventionAbigail G Cohen, Christina Cho, Emily Patterson, et al.
Molecular Cancer Research : MCR|November 15, 2022
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer CellsNoreen McBrearty, Christina Cho, Jinyun Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 5, 2019
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34<sup>+</sup> Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Valkal Bhatt, Patrick Hilden, et al.
Blood Advances|October 14, 2022
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemiaWarren B Fingrut, Boglarka Gyurkocza, Jessica Flynn, et al.
Pageof 10